I think it is unrealistic to expect a fall in cash burn. If anything it will increase. The cost of a trial continues as long as the trial. There is a huge amount of lab work on samples collected and this is on going. IVX also has potential for additional trials in the inhaled Nadilol alluded to and the new drug acquired. I don't have a precise programme on this but one would assume that they will start costing money in the near future
Add to My Watchlist
What is My Watchlist?
